안과 용품 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Ophthalmic Supply Market Size, Share & Trends Analysis Report By Product, By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,828,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,311,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,279,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

안과 용품 시장의 성장과 동향 :

Grand View Research의 최신 보고서에 따르면 세계 안과 용품 시장 규모는 2030년까지 226억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 4.75%의 성장률을 나타낼 것으로 예상됩니다.

이 시장에는 안과 질환의 진단, 치료 및 관리를 위해 설계된 다양한 제품과 솔루션이 포함됩니다.

백내장, 녹내장, 노인성 황반변성 등 안과 질환 증가는 시장 성장을 크게 촉진할 것입니다. 세계보건기구(WHO)에 따르면 전 세계 약 22억 명이 시각 장애의 영향을 받고 있습니다. 이 놀라운 통계는 이러한 증상에 대처하기 위한 효과적인 치료 옵션과 의료 용품에 대한 긴급한 필요성을 강조합니다.

업계가 복잡한 안질환 환자들의 치료 결과를 개선하기 위해 노력하는 가운데, 미충족된 환자 니즈에 대한 대응은 세계 시장에서 매우 중요한 초점이 되고 있습니다. 진행성 녹내장 및 희귀 망막 질환에 대한 보다 효과적인 치료법에 대한 요구가 기술 혁신의 원동력이 되고 있습니다. 기업들은 이러한 격차를 해소하기 위해 새로운 진단 도구와 치료 솔루션을 개발하고 있습니다. 예를 들어, 2022년 1월 알콘은 Ivantis, Inc.를 인수하여 Hydrus Microstent를 자사의 세계 수술 제품군에 포함시켰습니다.

안과 용품 시장 보고서 하이라이트

• 시력 관리 기기 부문은 2023년 41.5%의 가장 큰 매출 점유율로 시장을 주도했습니다. 이 부문은 시력 장애의 유병률 증가와 교정 솔루션에 대한 수요 증가로 인해 주도하고 있습니다. 이 분야에는 근시, 원시, 난시 관리에 필수적인 안경, 콘택트렌즈, 저시력 보조 장치 등 다양한 제품이 포함됩니다.
• 최종 용도별로는 병원 및 안과 클리닉 분야가 2023년 68.64%의 가장 큰 매출 점유율로 시장을 주도했습니다. 레이저 시력 교정, 망막 치료 등을 제공하는 전문 안과 클리닉의 성장이 안과 용품에 대한 수요를 더욱 촉진하고 있습니다. 이 부문의 우위는 종합적인 안과 치료를 제공하고 다양한 안과 질환을 관리하는 이러한 시설의 중요한 역할을 반영합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 안과 용품 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 안과 용품 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 안과 용품 시장 : 제품 추정·동향 분석

• 세계의 안과 용품 시장 : 제품 대시보드
• 세계의 안과 용품 시장 : 제품 변동 분석
• 세계의 안과 용품 시장, 제품별, 매출별
• 외과용 기기
• 진단 및 모니터링 기기
• 시력 케어 기기
• 기타

제5장 안과 용품 시장 : 최종 용도 추정·동향 분석

• 세계의 안과 용품 시장 : 최종 용도 대시보드
• 세계의 안과 용품 시장 : 최종 용도 변동 분석
• 세계의 안과 용품 시장 추정, 최종 용도별, 매출별
• 병원 및 안과
• 학술 및 연구실
• 기타

제6장 안과 용품 시장 : 지역 추정·동향 분석, 제품별·최종 용도별

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018년-2030년 :
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제7장 경쟁 구도

• 기업/경쟁 분류
• 벤더 구도
  • 주요 유통업체 및 채널 파트너 리스트
  • 주요 기업의 시장 점유율 분석, 2023년
  • Bausch Health Companies, Inc.
  • Alcon
  • Carl Zeiss Meditec AG
  • Johnson & Johnson Services, Inc.
  • HOYA Corporation
  • Banner Health
  • The Cooper Companies, Inc.
  • EssilorLuxottica
  • Canon Inc.
  • Glaukos Corporation.
  • TOPCON CORPORATION

LSH

영문 목차

영문목차

Ophthalmic Supply Market Growth & Trends:

The global ophthalmic supply market size is anticipated to reach USD 22.6 billion by 2030 and is projected to grow at a CAGR of 4.75% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a wide range of products and solutions designed for the diagnosis, treatment, and management of eye conditions.

The rise in eye disorders such as cataracts, glaucoma, and age-related macular degeneration significantly drives the market growth. According to the World Health Organization (WHO), approximately 2.2 billion people globally are affected by visual impairment. This alarming statistic underscores the urgent need for effective treatment options and medical supplies to address these conditions.

Addressing unmet patient needs is a crucial focus in the global market as the industry strives to improve outcomes for individuals with complex eye conditions. Innovations are driven by the need for more effective treatments for advanced glaucoma and rare retinal diseases. Companies are developing novel diagnostic tools and therapeutic solutions to address these gaps. For instance, in January 2022, Alcon acquired Ivantis, Inc., incorporating the Hydrus Microstent into its worldwide surgical product range.

Ophthalmic Supply Market Report Highlights:

• The vision care devices segment led the market with the largest revenue share of 41.5% in 2023. This segment is driven by the increasing prevalence of vision impairments and a growing demand for corrective solutions. It encompasses a broad range of products, including eyeglasses, contact lenses, and low-vision aids, essential for managing myopia, hyperopia, and astigmatism
• Based on end use, the hospital and eye clinics segment led the market with the largest revenue share of 68.64% in 2023. The growth of specialized eye care clinics, such as those offering laser vision correction and retina care, further boosts the demand for ophthalmic supplies. This segment's dominance reflects these facilities' crucial role in delivering comprehensive ophthalmic care and managing a broad range of eye health conditions

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. End Use Outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Ophthalmic Supply Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of eye diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing geriatric population
    • 3.2.1.4. Growing awareness and access to eye care
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High initial costs of ophthalmic equipment
    • 3.2.2.2. Complex regulatory environment
• 3.3. Ophthalmic Supply Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Ophthalmic Supply Market: Product Estimates & Trend Analysis

• 4.1. Global Ophthalmic Supply Market: Product Dashboard
• 4.2. Global Ophthalmic Supply Market: Product Movement Analysis
• 4.3. Global Ophthalmic Supply Market by Product, Revenue
• 4.4. Surgical Device
  • 4.4.1. Surgical device market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Diagnostic and Monitoring Devices
  • 4.5.1. Diagnostic and monitoring devices market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Vision Care Devices
  • 4.6.1. Vision care devices market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Other
  • 4.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Ophthalmic Supply Market: End Use Estimates & Trend Analysis

• 5.1. Global Ophthalmic Supply Market: End Use Dashboard
• 5.2. Global Ophthalmic Supply Market: End Use Movement Analysis
• 5.3. Global Ophthalmic Supply Market Estimates and Forecasts, By End Use, Revenue (USD Million)
• 5.4. Hospitals and Eye Clinics
  • 5.4.1. Hospitals and eye clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Academic and Research Laboratories
  • 5.5.1. Academic and research laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Ophthalmic Supply Market: Regional Estimates & Trend Analysis by Product and End Use

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Vendor Landscape
  • 7.2.1. List of key distributors and channel partners
  • 7.2.2. Key company market share analysis, 2023
  • 7.2.3. Bausch Health Companies, Inc.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Alcon
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Carl Zeiss Meditec AG
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Johnson & Johnson Services, Inc.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. HOYA Corporation
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Banner Health
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. The Cooper Companies, Inc.
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. EssilorLuxottica
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Canon Inc.
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Glaukos Corporation.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. TOPCON CORPORATION
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives

관련자료